Skip to main content
. 2012 Mar 20;2(2):e000636. doi: 10.1136/bmjopen-2011-000636

Table 1.

Antibiotic susceptibility of 31 Neisseria gonorrhoeae isolates from Bissau, Guinea-Bissau

Antibiotic (breakpoints) Susceptible (%) Intermediate (%) Resistant (%)
Penicillin G (S≤0.064/R>1.0)* 5 (16) 5 (16) 21 (68)
Ampicillin (S≤0.125/R>3.0) 10 (32) 0 21 (68)
Cefixime (S≤0.125/R>0.125)* 31 (100) 0 0
Ceftriaxone (S≤0.125/R>0.125)* 31 (100) 0 0
Cefuroxime (S≤0.064/R>1.0) 5 (16) 26 (84) 0
Azithromycin (S≤0.25/R>0.5)* 31 (100) 0 0
Erythromycin (S≤0.25/R>0.5) 26 (84) 3 (10) 2 (6)
Ciprofloxacin (S≤0.032/R>0.064)* 28 (90) 0 3 (10)
Spectinomycin (S≤64/R>64)* 31 (100) 0 0
Tetracycline (S≤0.5/R>1.0)* 8 (26) 0 23 (74)
Rifampicin (S≤0.125/R>32) 24 (77) 3 (10) 4 (13)
Gentamicin MIC range: 0.75–6 mg/l
Kanamycin MIC range: 8–32 mg/l
*

Breakpoints (for susceptible (S≤x mg/l) and resistant (R>y mg/l)) according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST; http://www.eucast.org) were used, when available.

All were β-lactamase producing.

MIC, minimum inhibitory concentration.